BRVE - Braveheart Bio, Inc.
Price:
--
--
|
PRICE TARGET:
$45.25
DETAILS
HIGH:
$48.00
LOW:
$40.00
MEDIAN:
$46.50
CONSENSUS:
$45.25
UPSIDE:
93.62%
SEC Filings
AI summaries extract footnotes, management discussion, and supplemental disclosures not found in the primary financial statements.
Summaries may contain errors.
No SEC filings available for BRVE.